000009530 001__ 9530
000009530 005__ 20240418145323.0
000009530 0247_ $$2DOI$$a10.6083/m326m241m
000009530 037__ $$aIR
000009530 041__ $$aeng
000009530 245__ $$aUtilization of brachytherapy for cervical cancer in Oregon
000009530 260__ $$bOregon Health and Science University
000009530 269__ $$a2022
000009530 336__ $$aAbstract
000009530 520__ $$aThe standard of care for locally advanced cervical cancer is external beam radiation (EBRT) and chemotherapy followed by a brachytherapy boost. Despite the body of evidence supporting the survival benefit of brachytherapy, studies have shown a decreased use of brachytherapy over time as well as low baseline brachytherapy use overall. This study hopes to better characterize the utilization of brachytherapy for cervical cancer in Oregon and identify disparities in delivery of care.
000009530 540__ $$fCC BY
000009530 542__ $$fIn copyright - joint owners
000009530 650__ $$aGynecology$$019790
000009530 650__ $$aBrachytherapy$$015785
000009530 650__ $$aNeoplasms$$022758
000009530 650__ $$aUterine Cervical Neoplasms$$016403
000009530 6531_ $$aoncology
000009530 6531_ $$aradiation therapy
000009530 6531_ $$acervical cancer
000009530 691__ $$aSchool of Medicine$$041369
000009530 7001_ $$aEakin, Adam$$uOregon Health and Science University$$041354
000009530 7001_ $$aWairiri, Loise$$uOregon Health and Science University$$041354
000009530 7001_ $$aStadtlander, William$$uOregon Health and Science University$$041354
000009530 7001_ $$aEmerson, Jenna$$uOregon Health and Science University$$041354
000009530 7001_ $$aBruegl, Amanda$$uOregon Health and Science University$$041354
000009530 7001_ $$aKahn, Jenna$$uOregon Health and Science University$$041354
000009530 711__ $$aResearch Week$$uOregon Health and Science University$$d2022
000009530 8564_ $$98137b211-37dc-4713-b4d1-e2b23c1b3862$$s63090$$uhttps://digitalcollections.ohsu.edu/record/9530/files/Eakin-Adam-OHSU-ResearchWeek-2022.pdf
000009530 905__ $$a/rest/prod/m3/26/m2/41/m326m241m
000009530 980__ $$aResearch Week